Nevada § 689B.0317 Required provision in policy covering treatment of prostate cancer concerning coverage for prostate cancer screening; prohibited act

Nevada Statutes

§ 689B.0317 — Required provision in policy covering treatment of prostate cancer concerning coverage for prostate cancer screening; prohibited act

Nevada § 689B.0317

Title 57INSURANCE

Ch. 689BGroup

Coverage

This text of Nevada § 689B.0317 (Required provision in policy covering treatment of prostate cancer concerning coverage for prostate cancer screening; prohibited act) is published on Counsel Stack Legal Research, covering Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Nev. Rev. Stat. § 689B.0317 (2026).

Text

1. A policy of group health insurance that provides coverage for the treatment of prostate cancer must provide coverage for prostate cancer screening in accordance with:

(a)The guidelines concerning prostate cancer screening which are published by the American Cancer Society; or

(b)Other guidelines or reports concerning prostate cancer screening which are published by nationally recognized professional organizations and which include current or prevailing supporting scientific data. 2. A policy of group health insurance that provides coverage for the treatment of prostate cancer must not require an insured to obtain prior authorization for any service provided pursuant to subsection 1. 3. A policy of group health insurance that provides coverage for the treatment of prostate cancer which

Free access — add to your briefcase to read the full text and ask questions with AI

1. A policy of group health insurance that provides coverage for the treatment of prostate cancer must provide coverage for prostate cancer screening in accordance with:
(a) The guidelines concerning prostate cancer screening which are published by the American Cancer Society; or
(b) Other guidelines or reports concerning prostate cancer screening which are published by nationally recognized professional organizations and which include current or prevailing supporting scientific data.
2. A policy of group health insurance that provides coverage for the treatment of prostate cancer must not require an insured to obtain prior authorization for any service provided pursuant to subsection 1.
3. A policy of group health insurance that provides coverage for the treatment of prostate cancer which is delivered, issued for delivery or renewed on or after July 1, 2007, has the legal effect of including the coverage required by subsection 1, and any provision of the policy or the renewal which is in conflict with subsection 1 is void.